Atlas FDA

Radiesse(+) Lidocaine

FDA premarket approval P050052/S119 · decided 2020-03-17

Approval details

PMA number
P050052
Supplement
S119
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Radiesse(+) Lidocaine
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2019-12-18
Decision date
2020-03-17
Days to decision
90 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Approval for a modification to the Lidocaine HCl shelf life specifications

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29